State Board of Administration of Florida Retirement System
BCLI

State Board of Administration of Florida Retirement System’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-893
Closed -$51K – 2388
2021
Q1 		$51K Hold
893
– – ﹤0.01% 2344
2020
Q4 		$61K Buy
+893
New +$122K ﹤0.01% 2316

Other funds holding BCLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Board of Administration of Florida Retirement System's BCLI Position: Q2 2021 in Review

State Board of Administration of Florida Retirement System sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q2 2021, closing a stake of 893 shares — an estimated $51K sold.

State Board of Administration of Florida Retirement System first reported a position in BCLI in Q4 2020 and held it in 2 quarters. The position peaked at $61K in Q4 2020. 57 funds tracked by Wall St. Rank hold BCLI as of Q2 2021.

  • State Board of Administration of Florida Retirement System reported no remaining BRAINSTORM CELL THERAPUTC position as of Q2 2021 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 893 BRAINSTORM CELL THERAPUTC shares in Q2 2021, an estimated $51K.
  • State Board of Administration of Florida Retirement System first reported a position in BRAINSTORM CELL THERAPUTC in Q4 2020 and held it in 2 quarters.
  • State Board of Administration of Florida Retirement System's BRAINSTORM CELL THERAPUTC position peaked at $61K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q2 2021.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2021, filed 10 Aug 2021.